Current surveillance has not demonstrated a substantial rise in cases linked to GLP-1 therapies
[1] [2] Other serious risks include pancreatitis, gallbladder disease, acute kidney injury, and hypersensitivity reactions
[3] The plasma concentration of GH during these peaks may range from 5 to even 45 ng/mL
Keep in mind that although some of the alternatives may not have an indication for weight loss, people taking these medications may experience weight loss with an improvement in managing their diabetes
It offers standardized dosing, predictable outcomes, and regulated safety for treating submental fat
Some people may experience only minor headaches, but for others who are prone to migraine, these headaches may progress to migraine attacks